- Home
- TENX vs FEMY Comparison
TENX vs FEMY Comparison
Compare TENX & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- FEMY
- Stock Information
- Founded
- TENX 1967
- FEMY 2004
- Country
- TENX United States
- FEMY United States
- Employees
- TENX N/A
- FEMY N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- FEMY Medical/Dental Instruments
- Sector
- TENX Health Care
- FEMY Health Care
- Exchange
- TENX Nasdaq
- FEMY Nasdaq
- Market Cap
- TENX 27.3M
- FEMY 30.2M
- IPO Year
- TENX N/A
- FEMY 2021
- Fundamental
- Price
- TENX $7.34
- FEMY $0.64
- Analyst Decision
- TENX Strong Buy
- FEMY Strong Buy
- Analyst Count
- TENX 3
- FEMY 3
- Target Price
- TENX $16.67
- FEMY $7.33
- AVG Volume (30 Days)
- TENX 96.6K
- FEMY 13.2M
- Earning Date
- TENX 11-14-2025
- FEMY 11-10-2025
- Dividend Yield
- TENX N/A
- FEMY N/A
- EPS Growth
- TENX N/A
- FEMY N/A
- EPS
- TENX N/A
- FEMY N/A
- Revenue
- TENX N/A
- FEMY $1,887,016.00
- Revenue This Year
- TENX N/A
- FEMY $103.55
- Revenue Next Year
- TENX N/A
- FEMY $148.13
- P/E Ratio
- TENX N/A
- FEMY N/A
- Revenue Growth
- TENX N/A
- FEMY 98.61
- 52 Week Low
- TENX $4.32
- FEMY $0.31
- 52 Week High
- TENX $8.24
- FEMY $1.80
- Technical
- Relative Strength Index (RSI)
- TENX 54.72
- FEMY 53.46
- Support Level
- TENX $7.00
- FEMY $0.57
- Resistance Level
- TENX $7.72
- FEMY $0.75
- Average True Range (ATR)
- TENX 0.49
- FEMY 0.11
- MACD
- TENX -0.02
- FEMY -0.00
- Stochastic Oscillator
- TENX 75.12
- FEMY 30.82
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.